Meet Dr. Joel Gagnier, CSO of FIFTY 1 Labs! From psychometrics & philosophy to naturopathic medicine, PhD in clinical epidemiology, and tenure at U Michigan & Western U. His journey built expertise in musculoskeletal health & research methods. Building the future of wellness!

$FITY CEO Paul Arora sits down with Dr. Joel Gagnier, our new Chief Science Officer, as he shares how decades of evidence-based research, industry leadership, and regulatory experience have prepared him to lead scientific innovation at Fifty1 AI Labs. #FITY #AIHealth #Biotech

$FITY is excited to welcome Dr. Joel Gagnier, ND, MSc, PhD, as Chief Science Officer at Fifty1 AI Labs. With over CAD $20M in research grants, 210+ peer-reviewed publications, and deep expertise in AI-driven clinical trials, Dr. Gagnier will help shape the future of personalized

Massive step forward for $FITY! Fifty 1 Labs, Inc. engages PCAOB auditing firm for 2024-2025 audits, gearing up for uplist to OTCQB. Unlocking visibility, liquidity, & investor trust in our AI-driven biotech mission! "Committed to transparency & transforming health." – CEO Paul

$FITY is leading the charge in AI-driven oncology! Leadership's new primer simplifies transportability principles to bridge data gaps worldwide, accelerating access to life-saving treatments in rare diseases & underserved areas. https://t.co/oUciXy7lZJ #HealthTech #Innovation

Fifty1 Labs ($FITY) partners with LUNR Aerospace to revolutionize space medicine with AI-driven drug repurposing! Targeting a $2B market by 2032, this collaboration leverages orbital research to advance astronaut health and dual-use innovations. Read more:

$FITY CEO Paul Arora breaks down the strategy: OTCQB by Q1 2026 → NASDAQ next. Why uplisting matters? Let’s talk momentum. ⬇️ #FITY #Uplisting #Growth

The goal is clear: position $FITY for transformative growth while creating long-term shareholder value. Big vision. Real momentum. #FITY #ShareholderValue #Uplisting

📊 Uplisting unlocks: • Higher liquidity for investors • Greater access to capital • Stronger credibility with institutions & partners These are the levers fueling our R&D + acquisitions pipeline. #FITY #Innovation

$FITY CEO Paul Arora breaks down the strategy: OTCQB by Q1 2026 → NASDAQ next. Why uplisting matters? Let’s talk momentum. ⬇️ #FITY #Uplisting #Growth

Ed Mills, Scientific Advisor at $FITY, calls our team “a spectacular group of high-level scientists” whose decades of experience bridge AI, global health, and clinical medicine. United by one language, we’re driving innovation that matters. https://t.co/FSKCUhGlTG #FITY #AI

$FITY & the Gates Foundation complete the largest-ever Sickle Cell study, mapping 10+ years of patient data to unlock faster, affordable treatments. AI + world-class partnerships = hope for millions worldwide. https://t.co/a0rXX5gPvm #GlobalHealth #AIDrugDiscovery #SickleCell

At Fifty1Labs (OTC: $FITY), our academic partnerships drive groundbreaking innovation. Senior Scientist James Orbinski explains how our team’s rigorous pursuit of truth—through data, hypothesis, and coherent science—unlocks the potential of AI to repurpose compounds and deliver

$FITY CEO breaks down what sets Fifty1 AI Labs apart: ✔ Off-patent drug repurposing — faster, safer, cheaper ✔ Real-world data + adaptive trials = regulatory acceleration ✔ Full-stack: from discovery to delivery to patient outcomes ✔ Global health roots to reach underserved

Huge milestone for $FITY! Fifty1 Labs & BioSpark AI unlock 2,000+ real-world treatment pathways, transforming 10,000+ case reports into a queryable database. This AI-driven breakthrough accelerates drug repurposing & functional medicine innovation. #AI #HealthTech #FITY Read

The Fifty1 Labs shareholder teleconference is now up! Hear from our elite leadership team, including Kristian Thorlund—top 1% cited expert in AI & trial methodology. Don’t miss it. https://t.co/0v29fV9Hxa $FITY #Biotech #AI

Fifty1 Labs Teleconference is now LIVE! Watch Fifty1's new world class management team talk strategy, roadmap, & answer questions: https://t.co/aT1G548xW4 $FITY #AI #HealthAndWellness #OTC

The Fifty 1 Labs $FITY Virtual Shareholder Call has been moved up to 12PM EST! Hear from Nobel Laureate Dr. James Orbinski and Fifty 1 Labs’ world-class leadership team. Don’t miss this powerful update!